** Shares of dental and medical supply firms fall after President Trump imposes reciprocal tariffs
** President Donald Trump imposed an additional 34% tariff on China and 20% tariff on EU; Japan with 24%, South Korea with 25% and Taiwan with 32%
** Brokerage Leerink Partners says dental manufacturers have a mix of sourcing from the US but also different European manufacturing footprints as well as Southeast Asia imports
** Shares of Dentsply Sirona XRAY.O down 7.8%, Envista NVST.N down 7.7%
** Dental cos XRAY and NVST have less than 10% revenue from Mexico, Leerink says
** Brokerage says the medical supply market will also be hit by high tariff costs from various Southeast Asian countries, and added "the biggest direct impact would be on PPE (personal protective equipment)- which is heavily sourced from Malaysia and other countries in the region"
** Shares of medical supplies distributors Henry Schein HSIC.O down 4% and Owens & Minor OMI.N fall 7.6%
** Leerink says OMI is better positioned as "it built significant manufacturing capacity in the U.S. during COVID"; adds the tariffs would mostly impact its products and healthcare solutions segment, which co announced it is actively looking to sell
** HSIC will be subject to PPE-related tariffs from SE Asia, "although the company’s recent diversification into specialty products will create some offset"- brokerage
** Up to last close XRAY down 27.8%, NVST down 16.3%, HSIC down 4.35 and OMI down 34.7% YTD
(Reporting by Sneha S K )
(( Sneha.SK@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.